Metoprolol is one of the most prescribed beta-blockers, used for high blood pressure, heart failure, heart rhythm problems, and migraine prevention. While many people tolerate it well, others experience debilitating fatigue, dizziness, cold hands and feet, exercise intolerance, and depression-like symptoms. If metoprolol side effects feel disproportionately bad for you, your CYP2D6 genetics may be amplifying the drug's effects beyond what your doctor intended.
Seek immediate medical attention if your resting heart rate drops below 40 bpm, if you experience fainting, severe dizziness, difficulty breathing, or chest pain. Never stop metoprolol abruptly, as this can cause dangerous rebound effects including rapid heart rate and blood pressure spikes.
Many metoprolol side effects are directly related to how much active drug is in your body. Fatigue, bradycardia (slow heart rate), dizziness, and cold extremities all get worse at higher effective drug levels. If you feel like you're getting side effects that don't match your dose, the issue may be that your body's actual drug exposure is higher than expected.
Metoprolol comes in two forms: immediate-release (Lopressor, metoprolol tartrate) and extended-release (Toprol XL, metoprolol succinate). The immediate-release form produces higher peak levels that can cause more pronounced side effects, while the extended-release form provides smoother drug levels throughout the day. Switching formulations sometimes resolves tolerability issues.
Beta-blockers limit your heart rate's ability to increase during exercise, which can make workouts feel much harder. Your maximum heart rate is reduced, and you may feel exhausted during activities that used to be manageable. This is an expected pharmacological effect, but its severity varies significantly between people.
CYP2D6 inhibitors like fluoxetine (Prozac), paroxetine (Paxil), bupropion (Wellbutrin), and quinidine can significantly increase metoprolol levels. If you recently started one of these medications and your metoprolol side effects worsened, the interaction is likely the cause.
Metoprolol is metabolized almost entirely by CYP2D6, making it one of the beta-blockers most affected by pharmacogenetics. While the clinical guidelines for metoprolol are more conservative than for some other CYP2D6 drugs, the impact on drug levels is dramatic.
CYP2D6 is responsible for breaking down metoprolol in the liver. Poor metabolizers can have metoprolol blood levels 3 to 5 times higher than normal metabolizers at the same dose. This translates directly into more pronounced heart rate reduction, lower blood pressure, more fatigue, and more side effects. About 5-10% of Caucasians are CYP2D6 poor metabolizers.
CYP2D6 poor metabolizers experience markedly higher metoprolol exposure, leading to greater reductions in heart rate and blood pressure. CPIC guidelines recommend starting at the lowest recommended dose for poor metabolizers and titrating cautiously, with careful monitoring for bradycardia. An alternative beta-blocker that doesn't depend on CYP2D6, such as bisoprolol or atenolol, may be a better choice for poor metabolizers who need beta-blockade without the exaggerated effects.
Pharmacogenetic testing makes sense if you're experiencing disproportionate side effects from metoprolol, especially fatigue, dizziness, or very low heart rate that seems out of proportion to your dose. It's also valuable if you're starting metoprolol for the first time and want to ensure the starting dose is appropriate for your genetics, or if you take other CYP2D6-metabolized medications and want to understand potential interactions.
Learn how genetics may affect your response to these related medications:
Beta-blockers reduce heart rate and blood pressure, which naturally lowers your energy level. But if you're experiencing extreme fatigue at a normal dose, it may be because your body isn't clearing metoprolol efficiently due to CYP2D6 genetics. Poor metabolizers can have drug levels 3-5x higher than normal metabolizers at the same dose.
No. Metoprolol and carvedilol are heavily dependent on CYP2D6. Atenolol is eliminated by the kidneys and isn't affected by CYP2D6 at all. Bisoprolol has a more balanced metabolic profile. If CYP2D6 status is causing problems with metoprolol, these alternatives may be better tolerated.
Yes, but you'll need to adjust your expectations. Beta-blockers limit your maximum heart rate, so target heart rate zones from before you started the medication no longer apply. You may feel like you're working harder at the same intensity. For CYP2D6 poor metabolizers, this effect can be more pronounced.
Find out how your DNA may influence your response to Metoprolol and other medications with a Gene2Rx pharmacogenetics report.
Get Your Report Try Our Free Calculator